Announcements

2 October 2025
Meet Us at the 2025 American Society of Tropical Medicine and Hygiene (ASTMH) Annual Meeting, 9–13 November 2025, Toronto, Canada


MDPI is excited to announce its participation as an exhibitor at the 2025 American Society of Tropical Medicine and Hygiene (ASTMH) Annual Meeting, which will be held in Toronto, Canada, from 9 to 13 November 2025.

ASTMH Annual Meeting 2025 aims to foster the exchange of scientific and clinical advances in tropical medicine, hygiene, and global health. This event will cover a variety of topical discussions, critical updates, and notable research findings.

The following open access journals will be represented:

Discover how MDPI can support your research and academic goals. Our team will be at the booth to discuss MDPI’s submission process, editorial support, and the benefits of open access publishing. Plus, enjoy exciting gifts and exclusive resources available only at our booth!

If you are planning to attend the conference, we would love to connect with you! Our delegates are eager to meet you in person and answer any questions you may have. For more details about the conference, please visit the following website: https://www.astmh.org/annual-meeting/

We look forward to seeing you there!

2 October 2025
MDPI INSIGHTS: The CEO's Letter #27 - OASPA 2025, COUNTER 5.1, UK Summit in London, MDPI at the Italian Senate

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI at OASPA 2025: Embracing the Complexity of Open Access

From 22 to 24 September, I joined the OASPA 2025 Annual Conference in Leuven, Belgium, where the theme, “Embracing the Complexity – How do we get to 100% Open Access?” tackled the hard questions about the future of scholarly communication.

With MDPI a longstanding member of the Open Access Scholarly Publishing Association (OASPA) and Platinum sponsor of the conference, I was invited to present and participate in important discussions on how we can continue to move the needle in Open Access (OA) publishing.

From 50% to 100% Open Access

Last year’s OASPA conference celebrated a major milestone – reaching 50% of global research outputs published as OA. But, as noted during the conference, this was the “easy” part. The challenge ahead is much tougher: how do we take OA from 50% to 100%? For many academics and institutions, OA is still relatively new, and thus it is essential for us to continue educating people as to what OA is, how it works, and why it matters.


Stefan Tochev (CEO, MDPI) presenting at OASPA’s 2025 Annual Conference in Leuven, Belgium.

MDPI’s perspective

At MDPI, we are fully committed to this. As a 100% OA publisher, our growth is inseparable from the success of OA itself. In many ways, MDPI is a byproduct of the global adoption of OA, and we play an important role in helping to advance it further.

I had the opportunity to share MDPI’s perspective in the panel discussion entitled: "Hello from the other side: views from fully Open Access journals using APCs," alongside industry colleagues from PLOS, eLife, AOSIS, and Frontiers.

Instead of giving a standard presentation, I highlighted aspects of MDPI that the audience might not be aware of. I also presented on the opportunities and challenges facing publishers that are already fully OA, the importance of diverse models in achieving 100% OA, and why OA is the baseline while Open Science is the future.

 Recognizing Gold OA

As part of the panel, I had undertaken to make some bold and provocative statements. I therefore emphasized a point that is sometimes overlooked: we didn’t reach 50% OA without Gold OA – it accounts for more than half of all OA publications today. And we certainly won’t reach 100% OA without it.

“By educating the community and working together, we can continue to take Open Science to the next level”


“When people speak about Gold OA and MDPI, they should ‘put some respek on our name.”

MDPI is a leader in Gold OA and has been a driver of this progress at scale.

While Gold OA and MDPI are sometimes slighted, both deserve recognition for their contributions to advancing Open Science globally.

I closed my presentation with a reminder that the good we do is sometimes overlooked, and that when people speak about Gold OA and MDPI, they should "put some respek on our name."

I’m pleased to have seen attendees sharing positive experiences with MDPI, reminding us that we bring real value to the OA movement and deserve a stronger reputation. We also engaged in constructive conversations about various topics, including cost transparency.

A few themes that I took away from the conference:

  • Quality and integrity matter as much as access. OA publishers must not lose sight of research integrity, inclusivity, and sustainability while pursuing 100% OA.
  • Global collaboration is essential. Policies, funding models, and infrastructure differ around the world, and we will need cross-border collaboration to make OA a truly global reality.
  • Open Science is the bigger story. OA is just the first step – the future lies in open data, open peer review, research reproducibility, etc.

“MDPI’s scale allows us to better support authors, reinvest in communities, and push Open Science forward”

How we communicate MDPI’s role

For us at MDPI, this is also a reminder of how we communicate externally. When we tell our story, we shouldn’t forget to start with the bigger picture – Open Science and Open Access. Then we connect it to MDPI, our journals, services, and initiatives, exemplifying the fact that we are part of a mission larger than ourselves.


MDPI colleagues Clàudia Aunós (Society Partnerships), Marta Colomer (External Affairs), Stefan Tochev (CEO), and Nikola Paunovic (Scilit), at OASPA’s 2025 Annual Conference in Leuven, Belgium.

The journey to 100% OA will not be simple. But by educating the community and working together, we can continue to take Open Science to the next level.

Impactful Research

MDPI becomes COUNTER 5.1 compliant across 480+ Journals

I’m pleased to share that MDPI has officially become COUNTER 5.1 compliant and has joined the COUNTER Registry.

For those who might not be familiar with it, COUNTER provides international standards for tracking and reporting how research is being used. By becoming COUNTER 5.1 compliant, MDPI can now deliver credible, comparable, and transparent usage reports across our entire journal portfolio.

“MDPI is showing that they want to be measured against the same yardstick as other publishers”

Why is this important?

Because usage statistics aren’t just numbers: they’re powerful tools that help our authors, institutions, and consortia understand the real impact of their research. With COUNTER compliant reports, our institutional partners can now make more informed decisions about publishing agreements, funding allocations, and the long-term value of Open Access.

In practical terms, MDPI will now provide Platform, Title, and Item Reports, with standardized usage views available at the institute and consortium level. These reports cover usage from January 2024 onwards and will be updated monthly. Institutions will be able to access them via SuSy, or automatically through the COUNTER API.

I’d like to highlight and thank Becky Castellon, our Institutional Partnerships Manager, who has played a key role in driving this project forward. Becky captured it perfectly when she said: "Through these usage reports, our global research community can access trustworthy data about how their work is being used and accessed

This information is often vital for reviewing publishing partnership agreements and for making informed decisions about future funding allocations."

We also received encouraging feedback from Tasha Mellins-Cohen, Executive Director at COUNTER Metrics:

"We’re delighted to see born-OA publishers engaging with COUNTER. Our normalised usage metrics are relied on as the basis for credible return-on-investment calculations by libraries worldwide. By adopting the COUNTER standard, MDPI is showing that they want to be measured against the same yardstick as other publishers."

For MDPI, this milestone is another step in our commitment to transparency, trust, and impact. By adopting COUNTER’s standards, we’re not just aligning with best practice; we’re ensuring that Open Access publishing is measured on the same terms as traditional publishing, proving its value in concrete and globally recognized ways.

This is an important milestone for MDPI, but more importantly for the researchers, librarians, and institutions we serve. Transparency builds trust, and COUNTER compliance helps us show the global reach and influence of Open Access publishing in the clearest way possible.


Inside Research


Lin Li (Publisher, MDPI), Stefan Tochev (CEO, MDPI, Prof. Chengkuo Lee (Editor-in-Chief, AI Sensors), and Constanze Schelhorn (Head of Indexing) at restaurant in Basel, Switzerland.

Welcoming Prof. Lee (EiC of AI Sensors) to Basel

On 11 September, we welcomed Prof. Dr. Chengkuo Lee, Editor-in-Chief of our new journal AI Sensors, to our Basel office. Prof. Lee is a high profiled researcher (h-index 104, 37,000+ citations), a longtime collaborator with MDPI (25 published articles), and has already chaired several AI Sensors (AIS)-related conferences with us, including the recent event in Kuala Lumpur, where AI Sensors held its first editorial board meeting.


Stefan Tochev (CEO, MDPI) showing Special Issue reprint books as part of a tour of MDPI’s Basel office.

Every journal has a story

During his visit, we exchanged ideas on how to build the journal’s identity and impact. A key takeaway that I shared was that every journal has a story: its vision, its purpose, and the community it brings together.

That story is what connects with readers and authors, beyond metrics alone.

I encouraged everyone working on journals to reflect: What is the story of your journal? And how can you bring that story to the forefront in how you communicate about it?

How MDPI supports new journals


Constanze Schelhorn (Head of Indexing, MDPI) presenting on the MDPI indexing process at the company’s headquarters in Basel.

We also shared with Prof. Lee how MDPI supports journals through our Institutional Open Access Program, indexing expertise, and the work of our Journal Relationship Specialists.

Launching a new journal is ambitious, but with our strong track record (93% Scopus and 87% Web of Science acceptance rates in 2024), Prof. Lee felt confident that AI Sensors will find its place in the scholarly landscape.

Having spent some hours together, it’s clear that Prof. Lee is not only an Editor-in-Chief but also an ambassador for MDPI. His leadership and collaboration reflect the mission MDPI by which MDPI lives: accelerating Open Access and advancing Open Science.

Special thanks to Constanze Schelhorn (Head of Indexing), Ting Leng (JRS, Managing Editor, AI Sensors), Lin Li (Publisher, AI Sensors), Aimar Xiong (Publisher), and Christian Eberhard (Office Administrator, Basel), for organizing and hosting the meeting.

Coming Together for Science

Highlights from the MDPI UK Summit in London

I was pleased to be back in the UK in September, supporting our Manchester team in hosting their first MDPI Summit in London. This day-and-a-half private event brought together 25 Chief Editors and Associate Editors to exchange knowledge, learn about latest developments at MDPI, and engage in discussions on advancing Open Science. The program included MDPI and guest presentations, and Q&A sessions.

Why these summits matter

Our Summits provide a platform to:

  • Share updates on the latest developments at MDPI, our editorial processes, research integrity practices, and indexing.
  • Highlight collaborations with institutions and societies in the region.
  • Offer external perspectives from guest speakers.
  • Create space for Chief Editors to share their insights, ask questions, network, and help shape MDPI’s path forward.

These gatherings are more than updates: they improve our relationships with Chief Editors, who serve not only as leaders of their journals but also as ambassadors for MDPI within the research community. We often hear that this type of event is unique, something many other publishers do not provide. It shows that we care and are willing to go the extra mile to recognize and engage our key collaborators.

MDPI and the UK: Key facts

  • With over 80,000 publications, the UK is MDPI’s eighth-largest contributor.
  • MDPI is the fourth-largest publisher in the UK, accounting for 11% of the country’s 89,526 Open Access publications in 2024.
  • We collaborate with more than 4,000 active UK Editorial Board Members, 48% of whom have an H-index above 26. This includes 49 Editors-in-Chief and 74 Section Editors-in-Chief.
  • MDPI maintains over 1,000 IOAP agreements worldwide, with 63 from the UK.

“We are willing to go the extra mile to recognize and engage our key collaborators”

Agenda highlights:

  • MDPI Overview, Open Access, and UK Collaboration – Stefan Tochev (CEO, MDPI)
  • MDPI Editorial Process – Dr. Michael O’Sullivan (Scientific Quality Advisor Lead, MDPI)
  • Research Integrity and Publication Ethics – Daisy Fenton (Research Integrity Specialist, MDPI)
  • Institutional Partnerships – Becky Castellon (Institutional Partnerships Manager, MDPI)
  • Promoting and Developing Your Journal – Prof. Fabio Tosti (Editor-in-Chief of NDT)
  • Indexing to Impact – Dr. Michael O’Sullivan (Scientific Quality Advisor Lead, MDPI)
  • Engaging our Academic Community – Jaime Anderson Anderson (UK Operations Manager, MDPI)
  • Closing Remarks – Stefan Tochev (CEO, MDPI)


MDPI colleagues Stefan Tochev (CEO), Jaime Anderson Anderson (UK Operations Manager), Dr. Michael O’Sullivan (Scientific Quality Advisor Lead), Becky Castellon (Institutional Partnerships Manager), Daisy Fenton (Research Integrity Specialist) at the MDPI UK 2025 Summit in London.

Thank you!

A special thank-you to the Manchester team and all colleagues behind the scenes who made this Summit a success. Your efforts are greatly appreciated. We look forward to building on this momentum with future Summits in Europe and beyond.


Closing Thoughts


Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI) and Stefan Tochev (CEO, MDPI) participating in a press conference at the Italiane Senate in Rome to promote the 2nd International Conference on Environmental Medicine (ICEM)

MDPI at the Italian Senate: Promoting Environmental Medicine and Open Science

On 16 September, Dr. Giulia Stefenelli (Scientific Communications Lead) and I had the honour of participating in a press conference at the Italian Senate in Rome, organized by the Italian Society of Environmental Medicine (SIMA) to promote the upcoming 2nd International Conference on Environmental Medicine (ICEM) (20–21 November 2025).

This is an important event for MDPI, as we are the exclusive publishing partner for ICEM and have recently launched a new journal with SIMA, further building our presence both in Italy and within this important field of research.

Why this matters

  • The promotion of ICEM has received extensive national media coverage (more than 15 mentions in major Italian outlets; see links below).
  • The press conference brought together leading policymakers, academics, and Nobel Laureates to emphasize the impact of environmental exposures and epigenetics on human health.
  • We were introduced to government ministries, university rectors, and influential stakeholders, which helps us bolster MDPI’s visibility and reputation in Italy.

Highlights

Nobel Laureate Sir Richard Roberts joined the discussion, underlining the importance of environmental medicine in shaping future health outcomes. Nobel Laureate Prof. Dr. Tong Zhu (Peking University) will also speak at the November conference.

Institutional representatives included the Italian Minister of the Environment and Energy Security, the Italian Undersecretary for Health, and senior officials from the World Health Organization.

In my closing remarks, I highlighted that:

“Over the past five years, about 65% of research published in Italy has been Open Access, compared to an average of 55% worldwide.”

Italian research ranked seventh among the top 20 countries in average citations during this period, reflecting its strong international influence. Not only is Italy producing a high volume of research; it is also producing research of outstanding quality.

MDPI’s role

This event was not only about promoting ICEM but also about showcasing MDPI’s commitment to Open Access and our ability to connect scientific publishing with leading academic, medical, and policy institutions.

As Giulia Stefenelli noted:

“This event was highly relevant for MDPI, as it not only showcased our strong commitment to OA but also emphasized our role in advancing important fields such as Environmental Medicine.”

Learn more

This moment at the Italian Senate shows how MDPI can connect publishing with science, policy, and society to help advance both Open Science and environmental health research on a global stage.

In Rome with Sir Richard Roberts (photo left) and Prof. Giuseppe Novelli (EiC of MDPI journal COVID).

Stefan Tochev
Chief Executive Officer
MDPI AG

30 September 2025
Nobel Prize — The Science Behind the Prize


Nobel Prizes are the world’s most prestigious recognition of scientific breakthroughs, honoring discoveries that push the boundaries of knowledge and reshape entire fields. They bring into the public eye researchers whose work might otherwise remain known only within specialized circles.

For many, winning a Nobel Prize is a surreal experience. Laureates often describe a mix of joy, humility, reflection, and gratitude for the teams and collaborators whose contributions made the achievement possible. Behind every Nobel-winning idea lies years of careful, incremental work—a process that often goes unseen.

When Prof. Steven Weinberg won the Nobel Prize in Physics in October 1979, his wife Louise, a legal scholar, reminded him to keep doing the ordinary hard work of science, joking: “Now you have to write some unimportant papers.” True to form, Weinberg continued to push the boundaries of our understanding of the Universe, showing that curiosity and dedication extend far beyond the moment of recognition (Hofmann 2025: https://www.mdpi.com/2073-8994/17/6/840).

Discover the science behind the world’s most transformative ideas

Over the years, dozens of Nobel laureates have published their work with MDPI, entrusting our open access journals to disseminate their findings to a global audience. As of 2024, more than 40 laureates have contributed over 115 articles across 35 journals, ranging from pioneering research on microRNAs and mRNA therapeutics, to fundamental insights in theoretical physics, and advances in structural biology.

We regularly spotlight how Nobel Prize–winning research intersects with the contributions of our authors. This not only celebrates the achievements of the laureates, but also underscores the role of open access in ensuring that transformative science reaches the widest possible audience.

On this page, we invite you to explore selected works by Nobel laureates within the MDPI portfolio, and to join us in celebrating the global impact of their ideas.


The Nobel Prize in Physiology or Medicine 2025 has been awarded to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi for for their discoveries concerning peripheral immune tolerance. MDPI sincerely invites you to explore research in a related field.

 

 

The Science Behind the Prize: 2025 Nobel Physiology or Medicine Roundtable
6 October 2025, 03:30 pm (CEST)
You are welcome to watch the recording here!



The Nobel Prize in Physics 2025 has been awarded to John Clarke, Michel H. Devoret and John M. Martinis for the discovery of macroscopic quantum mechanical tunnelling and energy quantisation in an electric circuit. MDPI sincerely invites you to explore research in a related field.

 

 

The Science Behind the Prize: 2025 Nobel Physics Roundtable
7 October 2025, 02:30 pm (CEST)
You are welcome to watch the recording here!




The Nobel Prize in Chemistry 2025 has been awarded to Susumu Kitagawa, Richard Robson and Omar M. Yaghi for the development of metal-organic frameworks. MDPI sincerely invites you to explore research in a related field.

 

 

29 September 2025
Vaccines | Notable Papers Published in 2024 in the “Vaccines against Tropical and other Infectious Diseases” Section

1. “Efficacy of Respiratory Syncytial Virus Vaccination to Prevent Lower Respiratory Tract Illness in Older Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”
by Matteo Riccò, Antonio Cascio, Silvia Corrado, Marco Bottazzoli, Federico Marchesi, Renata Gili, Pasquale Gianluca Giuri, Davide Gori and Paolo Manzoni
Vaccines 2024, 12(5), 500; https://doi.org/10.3390/vaccines12050500
Full text available online: https://www.mdpi.com/2076-393X/12/5/500

2. “Unveiling the Multifaceted Roles of ISG15: From Immunomodulation to Therapeutic Frontiers”
by Enrique Álvarez, Michela Falqui, Laura Sin, Joseph Patrick McGrail, Beatriz Perdiguero, Rocío Coloma, Laura Marcos-Villar, Céline Tárrega, Mariano Esteban, Carmen Elena Gómez et al.
Vaccines 2024, 12(2), 153; https://doi.org/10.3390/vaccines12020153
Full text available online: https://www.mdpi.com/2076-393X/12/2/153

3. “Exosome-Mediated Antigen Delivery: Unveiling Novel Strategies in Viral Infection Control and Vaccine Design”
by Daed El Safadi, Alexandre Mokhtari, Morgane Krejbich, Alisé Lagrave, Ugo Hirigoyen, Grégorie Lebeau, Wildriss Viranaicken and Pascale Krejbich-Trotot
Vaccines202412(3), 280; https://doi.org/10.3390/vaccines12030280
Full text available online: https://www.mdpi.com/2076-393X/12/3/280

4. “Development and Evaluation of an Immunoinformatics-Based Multi-Peptide Vaccine against Acinetobacter baumannii Infection”
by Sean Jeffreys, Megan P. Tompkins, Jadelynn Aki, Sara B. Papp, James P. Chambers, M. Neal Guentzel, Chiung-Yu Hung, Jieh-Juen Yu and Bernard P. Arulanandam
Vaccines202412(4), 358; https://doi.org/10.3390/vaccines12040358
Full text available online: https://www.mdpi.com/2076-393X/12/4/358

5. “Herpes Zoster and Cardiovascular Disease: Exploring Associations and Preventive Measures through Vaccination”
by Minako Yamaoka-Tojo and Taiki Tojo
Vaccines202412(3), 252; https://doi.org/10.3390/vaccines12030252
Full text available online: https://www.mdpi.com/2076-393X/12/3/252

6. “Immunity to Varicella Zoster Virus in Healthcare Workers: A Systematic Review and Meta-Analysis (2024)”
by Matteo Riccò, Pietro Ferraro, Salvatore Zaffina, Vincenzo Camisa, Federico Marchesi, Francesca Fortin Franzoso, Cosimo Ligori, Daniel Fiacchini, Nicola Magnavita and Silvio Tafuri
Vaccines202412(9), 1021; https://doi.org/10.3390/vaccines12091021
Full text available online: https://www.mdpi.com/2076-393X/12/9/1021

7. “Immunotherapeutic Strategies as Potential Treatment Options for Cutaneous Leishmaniasis”
by Andrea Lafleur, Stephane Daffis, Charles Mowbray and Byron Arana
Vaccines202412(10), 1179; https://doi.org/10.3390/vaccines12101179
Full text available online: https://www.mdpi.com/2076-393X/12/10/1179

8. “Live Attenuated Vaccines against Tuberculosis: Targeting the Disruption of Genes Encoding the Secretory Proteins of Mycobacteria”
by Raja Veerapandian, Shrikanth S. Gadad, Chinnaswamy Jagannath and Subramanian Dhandayuthapani
Vaccines202412(5), 530; https://doi.org/10.3390/vaccines12050530
Full text available online: https://www.mdpi.com/2076-393X/12/5/530

9. “Treatments and the Perspectives of Developing a Vaccine for Chagas Disease”
by Priscila Silva Grijó Farani, Kathryn Marie Jones and Cristina Poveda
Vaccines202412(8), 870; https://doi.org/10.3390/vaccines12080870
Full text available online: https://www.mdpi.com/2076-393X/12/8/870

10. “Immunogenicity and Protective Efficacy of a Multi-Antigen Mycobacterium tuberculosis Subunit Vaccine in Mice”
by Annuurun Nisa, Rachel Pinto, Warwick J. Britton, James A. Triccas and Claudio Counoupas
Vaccines202412(9), 997; https://doi.org/10.3390/vaccines12090997
Full text available online: https://www.mdpi.com/2076-393X/12/9/997

28 September 2025
Meet Us at Kidney Week 2025, 6–9 November 2025, Houston, USA


MDPI will attend ASN Kidney Week 2025, which will take place from 6 to 9 November 2025, at the George R. Brown Convention Center, in Houston, USA.

The American Society of Nephrology (ASN) invites you to participate in the largest and most influential international gathering of kidney professionals worldwide. Join the kidney community as we come together with a shared focus on improving the lives of over 850 million people across the globe. At Kidney Week 2025 in Houston, TX, you will have the opportunity to engage with more than 12,000 kidney professionals and experience the Scientific Exposition, which showcases the latest advances in treatment, research, and cutting-edge technology in nephrology. As the world’s premier nephrology meeting, Kidney Week offers exciting and challenging opportunities to exchange knowledge, discover the newest scientific and medical developments, and take part in engaging discussions with leading experts in the field.

MDPI is excited to participate in this prestigious event. We welcome you to visit MDPI’s booth, where you will be able to have face-to-face exchanges with our representatives, and learn more about our open access publishing services.

The following MDPI journals will be represented:

If you plan to attend this event, we encourage you to visit our booth and speak to our representatives. We are eager to meet you in person and assist you with any queries that you may have. For more information about the conference, please visit the official website: https://www.asn-online.org/kidneyweek.

25 September 2025
Meet Us at the 14th Leman China Swine Conference & World Swine Industry Expo, 18–20 October 2025, Changsha, China


Conference: 14th Leman China Swine Conference & World Swine Industry Expo
Date: 18–20 October 2025
Location: Changsha, China

MDPI will be attending the 14th Leman China Swine Conference & World Swine Industry Expo, which will be held between 18 and 20 October 2025, as an exhibitor. We welcome researchers from various backgrounds to visit our booth and share their latest ideas with us. 

Leman China Swine Conference is the largest pig farming industry conference in the world currently, adhering to the purpose of "providing Science-Driven Solutions for the global swine industry-China Focus". The conference aims to share research results and the latest information from authoritative experts around the world for Chinese pig farming practitioners and is committed to building an unbiased platform for sharing knowledge and experience, which has won high recognition from industry colleagues and led the event to being recognized as one of the most valuable conferences in the pig industry. 

The conference covers high-level content on swine production, disease surveillance, and control, the latest in research and development, and international perspectives on the swine industry. The event will provide interactive learning, with a forum for discussion and case studies with professional leaders. 

The following MDPI journals will be represented at the conference:

Our delegates look forward to meeting you in person at the booth and answering any questions that you may have. For more information, please visit https://www.lemanchina.com/.

24 September 2025
Meet Us at the American Public Health Association Annual Meeting and Expo (APHA 2025), 2–5 November 2025, Washington, D.C., USA


Conference:
APHA 2025 Annual Meeting and Expo
Date: 2–5 November 2025
Location: Washington, D.C., USA

The American Public Health Association was founded in 1872. The first APHA Annual Meeting and Expo took place in Cincinnati, Ohio, in 1873, and each year, approximately 12,000 public health professionals and partners from around the world participate in this event. The Annual Meeting garners many professionals across various disciplines, offering them a platform to engage and collaborate with others in the field and gain further insights. Moreover, research has shown that public health efforts to prevent disease are more cost-effective—and humane—than treating chronic health conditions.

The following MDPI journals will be represented at APHA 2025:

Our delegates look forward to meeting you in person at our booth and answering any questions you may have. For more information regarding this conference, please visit the following link: https://www.apha.org/events-and-meetings/annual.

11 September 2025
Vaccines | Interview with Dr. Stephanie Longet—Session Chair of the 3rd International Online Conference on Vaccines


  1. Could you please briefly introduce yourself? 
    I am Dr. Stephanie Longet, and I am an Assistant Professor at the University of Saint-Etienne in France.
    My main research interests are the development of intranasal vaccine strategies against respiratory viruses. We are testing novel strategies to deliver vaccine components to the nasal mucosa, and we are evaluating novel adjuvants to improve airway memory immunity. In addition, we are developing novel human in vitro models and techniques to measure respiratory memory immunity post-infection or post-vaccination in humans.
  2. What do you think of the development status of and trends in open access publishing?
    Open access publishing is crucial to share knowledge with the whole community of researchers, including researchers in LMIC. Open access publishing is also very useful for a large audience to access scientific knowledge and recent data in the field of vaccines.
  3. What is your impression of the Vaccines journal?
    The Vaccines journal publishes a lot of studies that evaluate novel vaccine technologies and strategies to improve the efficacy of vaccines at preclinical and clinical stages. Novel platforms are discussed. There are also a lot of reviews explaining the current status of a large range of vaccinations in different countries. This journal covers all essential topics linked to vaccine research.
  4. What do you think will be the research hotspots in the field of vaccines in the next few years, and can you describe them to us?
    Mucosal vaccines will remain a hotspot because they have the ability to induce protection at the site of infection. However, it is still very challenging to develop vaccines that induce protective immune responses at mucosal surfaces.
    I also presume there will be new mRNA vaccines that will be licensed. The versatility of this platform is very promising.
    Developing multivalent vaccines will also be a research hotspot. Having one vaccine formulation that targets several pathogens would also be beneficial.
  5. Can you give any advice on academic research for young scholars in related fields?
    Developing safe and effective vaccines is a challenging journey. Only a few vaccine candidates will be tested in clinical trials, but never give up, and all data, even negative data, will be helpful to improve your strategies.
  6. Could you kindly share with us your thoughts and outlook on this E-conference?
    The sessions’ topics highlight the current challenges in the vaccine field. I hope a lot of worldwide researchers will attend this e-conference.
  7. Could you please provide a brief introduction to the session you are chairing, titled “Mucosal Vaccines for Respiratory Disease”?
    The goal of this session is to explore some of the latest developments and future directions in mucosal vaccine research for respiratory pathogens. It will bring together experts to discuss innovative platforms, methods to study immunological mechanisms in the respiratory mucosa, correlates of protection, preclinical and clinical insights, and translational hurdles.

3 September 2025
Join Us at the MDPI at the University of Toronto Career Fair, 23 September 2025, Toronto, ON, Canada


Date: 23 September 2025
Time: 11:00 a.m.–4:30 p.m
Location: The Chelsea Hotel, 33 Gerrard Street West, Toronto

MDPI is thrilled to announce our participation in the University of Toronto’s largest career fair, taking place at the St. George Downtown Campus. This exciting event brings together thousands of students, graduates, and professionals looking to connect with top employers and explore career opportunities.

We invite all attendees to visit the MDPI booth to discover how you can be part of one of the world’s leading open access academic publishers. Whether you are passionate about scientific research, editorial work, marketing, or supporting global innovation in publishing, we want to meet YOU!

What to expect at our booth:

  • Learn more about MDPI’s mission and global impact;
  • Explore exciting career opportunities in publishing, editorial, communications, and more;
  • Network with our team and ask questions about working at MDPI.

Whether you’re just starting your career or looking to take the next step, don’t miss this opportunity to connect with MDPI. Bring your resume, your curiosity, and your questions—we look forward to seeing you there!

For additional information on the Career Fair and Open MDPI positions, please visit the following links:

2 September 2025
Meet Us at the 4th Asia Pacific Rickettsial Conference 2025, 29 September–1 October 2025, Penang, Malaysia


Conference: 4th Asia Pacific Rickettsial Conference
Organization: Malaysian Society of Parasitology and Tropical Medicine
Date: 29 September–1 October 2025
Place: Penang, Malaysia

MDPI will be attending the 4th Asia Pacific Rickettsial Conference as an exhibitor. This meeting will be held in Penang, Malaysia, from 29 September to 1 October 2025.

The objective of the 4th Asia Pacific Rickettsial Conference is to garner experts, researchers and healthcare professionals from around the world to explore advancements in the study and management of rickettsial and other tropical diseases. This event aims to explore innovative approaches to the surveillance, prevention, and treatment of these diseases, particularly highlighting integrated strategies that address the complexities of these diseases in both public and veterinary health contexts.

The scope of this conference includes, but is not limited to, acarology; rickettsial diseases; tick-borne diseases; flea-borne diseases; scrub typhus; zoonoses; epidemiology; vector biology and control; rickettsial pathogenesis; diagnostics in rickettsial diseases; and rickettsial surveillance and outbreak response. It additionally seeks to explore geospatial analysis in the mapping of rickettsial disease; novel rickettsial infections; emerging and re-emerging rickettsial diseases; and treatment and vaccines for rickettsial infections.

The following MDPI journals will be represented:

If you are planning to attend this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about this event, please visit the following website: https://www.aprc4.com/.

Back to TopTop